NAPROSYN
ATNAHS PHARMA UK LIMITED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is NAPROSYN discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that NAPROSYN 375MG has been permanently discontinued (last updated August 1, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
TEVA-NAPROXEN
TEVA CANADA LIMITED
ANAPROX DS
SEARCHLIGHT PHARMA INC
NAPROXEN-NA
PRO DOC LIMITEE
NAPROXEN-NA DF
PRO DOC LIMITEE
PEDIAPHARM NAPROXEN SUSPENSION
MEDEXUS PHARMACEUTICALS INC.
TEVA-NAPROXEN EC
TEVA CANADA LIMITED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02162415
Strength
375MG
Dosage Form
TABLET (ENTERIC-COATED)
Route
ORAL
Active Ingredient
NAPROXEN
Tier
Unrated
Last Updated
2024-08-01
Reason for Shortage
Other (Please describe in comments)
Other Products from ATNAHS PHARMA UK LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.